217 related articles for article (PubMed ID: 38335705)
1. Overview on biotics development.
Roux AE; Langella P; Martin R
Curr Opin Biotechnol; 2024 Apr; 86():103073. PubMed ID: 38335705
[TBL] [Abstract][Full Text] [Related]
2. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
Martyniak A; Medyńska-Przęczek A; Wędrychowicz A; Skoczeń S; Tomasik PJ
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944546
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
Wasilewski A; Zielińska M; Storr M; Fichna J
Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis.
Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM
Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375
[TBL] [Abstract][Full Text] [Related]
5. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
Roy S; Dhaneshwar S
World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
Heilpern D; Szilagyi A
Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
8. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis.
Jadhav A; Jagtap S; Vyavahare S; Sharbidre A; Kunchiraman B
Front Cell Infect Microbiol; 2023; 13():1268041. PubMed ID: 38145046
[TBL] [Abstract][Full Text] [Related]
9. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
10. Overview of the Importance of Biotics in Gut Barrier Integrity.
Kocot AM; Jarocka-Cyrta E; Drabińska N
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
[TBL] [Abstract][Full Text] [Related]
11. Probiotics and prebiotics in Crohn's disease therapies.
Lichtenstein L; Avni-Biron I; Ben-Bassat O
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
[TBL] [Abstract][Full Text] [Related]
12. Prebiotics, synbiotics and inflammatory bowel disease.
Steed H; Macfarlane GT; Macfarlane S
Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
[TBL] [Abstract][Full Text] [Related]
13. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
14. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
[TBL] [Abstract][Full Text] [Related]
15. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
[TBL] [Abstract][Full Text] [Related]
16. Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics.
Yadav MK; Kumari I; Singh B; Sharma KK; Tiwari SK
Appl Microbiol Biotechnol; 2022 Jan; 106(2):505-521. PubMed ID: 35015145
[TBL] [Abstract][Full Text] [Related]
17. Nutritional Support and Probiotics as a Potential Treatment of IBD.
Tarasiuk A; Eibl G
Curr Drug Targets; 2020; 21(14):1417-1427. PubMed ID: 32364071
[TBL] [Abstract][Full Text] [Related]
18. How to Improve Health with Biological Agents-Narrative Review.
Zawistowska-Rojek A; Tyski S
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565671
[TBL] [Abstract][Full Text] [Related]
19. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Oka A; Sartor RB
Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances and Understanding of Using Probiotic-Based Interventions to Restore Homeostasis of the Microbiome for the Prevention/Therapy of Bacterial Diseases.
Suchodolski JS; Jergens AE
Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
